Month: March 2023

Indaptus Therapeutics Reports Fourth Quarter and Year-End 2022 Financial Results and Provides Corporate Update

Written by Customer Service on March 17, 2023. Posted in Earnings Releases And Operating Results.

Enrollment Underway in Phase 1 Clinical Trial of Decoy20 for Treatment of Solid Tumors with First Patient Dosed In March 2023 NEW YORK, March 17, 2023 (GLOBE NEWSWIRE) — Indaptus Therapeutics, Inc. (Nasdaq: INDP) (“Indaptus” or the “Company”), today announced financial results for the fourth quarter and fiscal year ended December 31, 2022 and provided a corporate update. “With the initiation of our INDP-D101 trial at the end of December 2022 and the subsequent dosing of our first patient in the first cohort, we are well underway in our Phase 1 trial of Decoy20 for the treatment of solid tumors,” said Jeffrey Meckler, chief executive officer of Indaptus. “Following the initial dosing we were encouraged to learn that the subject experienced manageable and expected adverse events related to the immune response we anticipated. We are...

AGF Announces March 2023 Cash Distributions for Certain AGF ETFs

Written by Customer Service on March 17, 2023. Posted in Dividend Reports And Estimates.

TORONTO, March 17, 2023 (GLOBE NEWSWIRE) — AGF Investments Inc. (TSX:AGF.B) (AGF) today announced the March 2023 cash distributions for AGF Systematic Global Multi-Sector Bond ETF, AGF Systematic Global Infrastructure ETF, AGF Global Sustainable Growth Equity ETF and AGF Global Opportunities Bond ETF, which pay quarterly distributions. Unitholders of record on March 27, 2023 will receive cash distributions payable on March 31, 2023. Details regarding the final “per unit” distribution amounts are as follows:ETF Ticker Exchange Cash Distribution Per Unit ($)AGF Systematic Global Multi-Sector Bond ETF QGB NEO Exchange $0.17AGF Systematic Global Infrastructure ETF QIF NEO Exchange $0.21AGF Global Sustainable Growth Equity ETF AGSG NEO Exchange $0.01AGF Global Opportunities Bond ETF AGLB NEO Exchange $0.17Further...

Form 8.3 – [EMIS GROUP PLC 16 03 2023] – (CGWL)

Written by Customer Service on March 17, 2023. Posted in Mergers And Acquisitions.

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION(a) Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree EMIS GROUP PLC(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e) Date position held/dealing...

Form 8.3 – [DEVRO PLC 16 03 2023] – (CGWL)

Written by Customer Service on March 17, 2023. Posted in Mergers And Acquisitions.

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION(a) Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree DEVRO PLC(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e) Date position held/dealing...

Wrap® to Host Investor Insights Webcast on March 23, 2023

Written by Customer Service on March 17, 2023. Posted in Public Companies.

TEMPE, Ariz., March 17, 2023 (GLOBE NEWSWIRE) — Wrap Technologies, Inc. (Nasdaq: WRAP) (“Wrap” or the “Company”), a global leader in innovative public safety technologies and services, will host a third edition of its Investor Insights webcast on March 23, 2023. During the webcast, Wrap executives will recap the Company’s attendance at the World Police Summit and take related questions from investors. Interested parties may submit questions to the Company prior to the webcast at WRAP@gatewayir.com by 8:00 p.m. Eastern time on Wednesday, March 22, 2023. Questions will be addressed based on the relevance to the topics of this webinar and public disclosure rules. Date: Thursday, March 23, 2023Time: 10:00 AM Eastern time (7:00 AM Mountain time)Webcast Link: Click here to register Please join the webcast 5-10 minutes prior to the start...

Tiziana Life Sciences Announces Purchase of Common Shares by Chairman and Acting CEO

Written by Customer Service on March 17, 2023. Posted in Public Companies.

NEW YORK, March 17, 2023 (GLOBE NEWSWIRE) — Tiziana Life Sciences Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies via novel routes of drug delivery, today announces that it has been notified that Gabriele Cerrone, its Chairman and Acting Chief Executive Officer, purchased 25,000 common shares at $0.58 per share, bringing his total holding to 38,640,737 common shares. About ForalumabActivated T cells play an important role in the inflammatory process. Foralumab, the only fully human anti-CD3 monoclonal antibody (mAb), binds to the T cell receptor, dampens inflammation by modulating T cell function, thereby suppressing effector features in multiple immune cell subsets, an effect demonstrated in patients with COVID and with multiple sclerosis, as well as...

VitalHub Announces Q4 and Fiscal Year 2022 Conference Call Date

Written by Customer Service on March 17, 2023. Posted in Earnings Releases And Operating Results.

TORONTO, March 17, 2023 (GLOBE NEWSWIRE) — VitalHub Corp. (the “Company” or “VitalHub”) (TSX: VHI) (OTCQX:VHIBF) is pleased to announce that it will release its financial results for its fiscal and quarter ended December 31st, 2022, after market close on March 23, 2023. The Company will subsequently hold a conference call via Zoom on March 24th, 2023, at 9:00am EST hosted by CEO Dan Matlow and CFO Brian Goffenberg with a Q&A session to follow. To register for the conference call please visit: https://us02web.zoom.us/webinar/register/WN_IpaEIPreQQCGNxcPeh6fdQ ABOUT VITALHUB: Software for Health and Human Services providers designed to simplify the user experience and optimize outcomes. VitalHub provides technology to Health and Human Services providers including Hospitals, Regional Health Authorities, Mental Health, Long Term...

Peerless Asset Quality and High-Potential Prospects Position Barrick for Profitable Growth

Written by Customer Service on March 17, 2023. Posted in Public Companies.

All amounts expressed in US dollars TORONTO, March 17, 2023 (GLOBE NEWSWIRE) — Barrick Gold Corporation (NYSE:GOLD)(TSX:ABX) – The past year marked a major milestone in Barrick’s journey to becoming the world’s most valued gold and copper mining company, with the foundational targets of the new business created by the Merger1 having largely been met, and its greater goals now within reach, says president and chief executive Mark Bristow with the publication of the company’s 2022 annual report today. “North America is Barrick’s value foundation and the true benefits of our creation of the Nevada Gold Mines complex are now becoming evident in the form of mineral resource growth and new discoveries. The quality and prospectivity of its portfolio cannot be overstated,” he said. “In Central America the plant expansion project we initiated...

Akero Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results

Written by Customer Service on March 17, 2023. Posted in Earnings Releases And Operating Results.

SOUTH SAN FRANCISCO, Calif., March 17, 2023 (GLOBE NEWSWIRE) — Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company developing transformational treatments for patients with serious metabolic diseases marked by high unmet medical need, today reported fourth quarter and full year financial results for the period ending December 31, 2022. “The wins we celebrated in 2022 further solidify our confidence in efruxifermin (EFX) as a potential best-in-class FGF21 analog addressing all core drivers of NASH disease progression,” said Andrew Cheng, M.D., Ph.D., president and chief executive officer of Akero. “The statistically significant histology and secondary endpoint results from September’s topline HARMONY trial readout followed by EFX’s Breakthrough Therapy Designation in December further validate EFX’s potential to address...

Guardian Capital Announces March 2023 Distributions for Guardian Capital ETFs

Written by Customer Service on March 17, 2023. Posted in Dividend Reports And Estimates.

TORONTO, March 17, 2023 (GLOBE NEWSWIRE) — Guardian Capital LP announces the following regular cash distributions for the period ending March 31, 2023, in respect of the ETF series of the Guardian Capital funds listed below (the “Guardian Capital ETFs”). In each case, the distribution will be paid on March 31, 2023 to unitholders of record on March 27, 2023. The ex-dividend date in each case is March 24, 2023. Guardian Capital ETFs Series of ETF Units DistributionFrequency TSX TradingSymbol Distribution Amount(per ETF Unit)Guardian Directed Equity Path ETF Hedged ETF Units Monthly GDEP $0.0746Guardian Directed Equity Path ETF Unhedged ETF Units Monthly GDEP.B $0.0684Guardian Directed Premium Yield ETF Hedged ETF Units Monthly GDPY $0.1231Guardian Directed Premium Yield ETF Unhedged ETF Units Monthly GDPY.B $0.1133GuardPath™ Managed...

Month: March 2023

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals